| Phase 3 |
| NCT07700979 |
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination… |
Gastric / Gastroesophageal Junction Adenocarcinoma |
Recruiting |
2026-09-29 |
| NCT07412613 |
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch… |
Resectable Colon Cancer |
Recruiting |
2026-04-22 |
| NCT06928389 |
Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer |
Non-Small Cell Lung Cancer |
Recruiting |
2026-04-09 |
| NCT06767527 |
AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally… |
Triple-Negative Breast Cancer (TNBC) |
Recruiting |
2026-03-16 |
| NCT07010263 |
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell… |
Small Cell Lung Cancer |
Recruiting |
2026-03-05 |
| NCT06951503 |
AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer |
Colorectal Adenocarcinoma |
Recruiting |
2026-03-04 |
| NCT06953999 |
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic… |
Pancreatic Cancer |
Recruiting |
2026-03-04 |
| NCT07023315 |
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for… |
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma |
Recruiting |
2026-02-11 |
| NCT05489289 |
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After… |
Hepatocellular Carcinoma |
Recruiting |
2025-03-12 |
| NCT06371157 |
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE)… |
Hepatocellular Carcinoma |
Recruiting |
2025-03-12 |
| NCT06617416 |
A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC |
NSCLC (Non-small Cell Lung Cancer) |
Recruiting |
2025-03-12 |
| NCT06601335 |
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head… |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
2024-11-14 |
| NCT06341335 |
A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal… |
Gastric and Gastroesophageal Junction Adenocarcinoma |
Recruiting |
2024-06-24 |
| NCT05499390 |
AK112 in Advanced Non-Small Cell Lung Cancer |
Advanced Non-small-cell Lung Cancer |
Active, Not Recruiting |
2026-03-09 |
| NCT05184712 |
Phase 3 Clinical Study of AK112 for NSCLC Patients |
Non-Squamous Non-small Cell Lung Cancer |
Active, Not Recruiting |
2026-03-04 |
| NCT07449780 |
A Study of AK104 (SC) in Combination With Oxaliplatin and Capecitabine (XELOX) Versus… |
Gastric / Gastroesophageal Junction Adenocarcinoma |
Not Yet Recruiting |
2026-03-04 |
| NCT06591520 |
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced… |
Biliary Tract Cancer |
Active, Not Recruiting |
2026-01-21 |
| NCT04982237 |
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line… |
Cervical Cancer |
Active, Not Recruiting |
2025-11-19 |
| NCT05840016 |
AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer |
Advanced Squamous Non Small Cell Lung Cancer |
Active, Not Recruiting |
2025-05-02 |
| NCT04974398 |
A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic… |
Nasopharyngeal Carcinoma |
Active, Not Recruiting |
2025-04-13 |
| NCT06767540 |
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis |
Atopic Dermatitis |
Not Yet Recruiting |
2025-01-10 |
| NCT05235516 |
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally… |
Locally Advanced Cervical Carcinoma |
Active, Not Recruiting |
2024-08-13 |
| NCT05990127 |
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1%… |
Locally Advanced or Metastatic NSCLC |
Not Yet Recruiting |
2023-08-14 |
| Phase 2 |
| NCT07591090 |
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer |
Advanced Breast Cancer |
Recruiting |
2026-07-22 |
| NCT07669779 |
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung… |
Advanced Non Small Cell Lung Cancer (NSCLC) |
Recruiting |
2026-07-14 |